UBS Lowers its Price Target on Lazard, Inc. (LAZ) to $48 from $59 and Maintains a Neutral Rating

Core Viewpoint - Lazard, Inc. is identified as one of the most undervalued financial stocks to buy, despite recent price target reductions by major banks [1][2]. Group 1: Price Target Adjustments - UBS lowered its price target for Lazard to $48 from $59 while maintaining a Neutral rating [1]. - Goldman Sachs reduced its price target to $46 from $53 and kept a Sell rating, citing a year-over-year increase in investment banking volumes of about 4% but noting potential negative growth due to geopolitical uncertainties [2]. Group 2: Financial Performance - As of February 28, 2026, Lazard reported preliminary assets under management (AUM) of approximately $277.7 billion, which included $8.9 billion in market appreciation and $4.2 billion in net inflows, offset by $0.8 billion in foreign exchange depreciation and a $1.5 billion decrease from the sale of its stake in Edgewater Funds [3]. Group 3: Company Overview - Lazard operates as a financial advisory and asset management firm across various regions, including the Americas, Europe, the Middle East, Africa, and the Asia Pacific, through its Financial Advisory and Asset Management segments [5].